EuroClonality-NDC assay
The EuroClonality-NDC assay allows you to detect immunoglobulin and T cell receptor rearrangements, translocations, mutations and copy number alterations in a single test.
About EuroClonality-NDC
An integrated tool covering
most genomic alterations
The Myeloid-NDC assay is intended for the integrated detection of chromosomal translocations, copy number alterations and mutations in AML, MDS and MPN, from just 100 ng of DNA.
About Myeloid-NDC
Universal Protocol Bespoke Solutions.
Bespoke NGS solutions for different clinical indications, without compromising in accuracy, content, performance or simplicity.
Download Resources
The future of fast accurate testing.
By encompassing all our NGS assays into a single universal workflow, you can achieve higher economy of scales and faster turnaround times for all your samples, irrespective of cancer type or laboratory throughput.
It’s that simple: 1 universal protocol, up to 8 bespoke assays, 2 days laboratory work, 1 day analysis… all done!
EuroClonality-NDC assay
Our first product, the EuroClonality-NDC assay can detect IG/TR rearrangements and translocations, sequence variants and copy number alterations, all in a single test.
Designed and developed by the EuroClonality-NGS working group.
Myeloid-NDC assay
Our first 2024 product, the Myeloid-NDC assay is intended for the integrated and qualitative detection of chromosomal translocations, copy number variants (CNV) and sequence variants from suspected or confirmed cases of myeloid malignancies.
